Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial
JAMA Oncol 2021 Oct 01;7(10)1529-1535, E Martinelli, G Martini, V Famiglietti, T Troiani, S Napolitano, F Pietrantonio, D Ciardiello, M Terminiello, C Borrelli, PP Vitiello, F De Braud, F Morano, A Avallone, N Normanno, A Nappi, E Maiello, T Latiano, A Falcone, C Cremolini, D Rossini, G Santabarbara, C Pinto, D Santini, C Cardone, N Zanaletti, A Di Liello, D Renato, L Esposito, F Marrone, F CiardielloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.